Immunoprecipitation Market - Global Industry Analysis

Immunoprecipitation Market

Immunoprecipitation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Biotechnology Report Format : PDF Report Code: ZMR-6525 Status : Upcoming

Description

Global Immunoprecipitation Market: Overview

Immunoprecipitation is the method used for isolating an antigen with the use of a specific antibody non-covalently or covalently coupled to a sedimentable matrix. In modern cell biology, it is the most widely used technique especially to probe protein-protein interaction. The rapid increase in clinical research has boosted the demand for immunoprecipitation.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Immunoprecipitation Market: Growth Factors

The global immunoprecipitation market is growing at a speedy rate. Some of the important factors that are augmenting the growth of the global market include the rapidly growing life science industry, increase in investment & funding in biopharmaceutical research, and growing R&D activities in genomics & immunotherapy. Immunoprecipitation is also widely used in the process of drug development. Over the past decade, there is an increase in the number of new drugs approved annually. From 2010 to 2019, per year on average FDA has approved 38 new drugs which is 60% more than the yearly average over the previous decade. Thus, with the growing prevalence of chronic diseases and the increase in the need for effective treatments, pharmaceuticals and the biotechnology industry are majorly spending on discovering and testing new drugs. This is also spurring the demand for immunoprecipitation testing. In addition to this, the increase in the development of reagents and kits to fulfill the growing demand for immunoprecipitation and the growing focus towards personalized medicines is equally contributing to the growth of the global immunoprecipitation market. Moreover, growing demand for ribonucleic acid (RNA) immunoprecipitation & individual IP and huge investments in the healthcare infrastructure will fuel the growth of the global immunoprecipitation market over the forecast period. Furthermore, advancement in the genomics sector may further create numerous opportunities for the growth of the global market over the forecast period. However, the availability of alternatives for immunoprecipitation may impede the growth of the global market.

The global immunoprecipitation market is witnessing rapid growth during the forecast period. Increasing demand for antigen test and vaccine developments is fostering market growth. Further, most of the government allowed the transport of medical tools, test kits, and reagents during the pandemic period owing to crucial needs. This has also supported the continuous sale of reagents and kits required for immunoprecipitation. However, demand for immunoprecipitation is expected to increase over the forecast period owing to the rapid surge in research and biological drug development. Many biological companies have diverted their focus to develop efficient vaccines to prevent COVID-19 infections which is expected to support the market growth at a significant rate.

Global Immunoprecipitation Market: Segmentation

The global immunoprecipitation market is bifurcated based on product, type, end-use, and region. Based on product, the global immunoprecipitation market is categorized into kits and reagents. By type, the global market is segmented as protein complex, individual protein, chromatin, tagged proteins, and ribonucleoprotein. The end-use segment is comprised of pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs).

Global Immunoprecipitation Market: Regional Analysis

North America is expected to hold the largest share in the global immunoprecipitation market during the forecast period. The most prominent factors that are fostering the growth of the market in the region include an increase in research & development investments by biological and pharmaceutical companies. The U.S. is expected to hold the dominant market position in North America. This is mainly due to rapid expansion of the life science sector. The immunoprecipitation market in Asia Pacific is anticipated to show rapid growth during the forecast period. Factors such as large number of biological & pharmaceutical companies and rising investments in research & development are factors projected to spur the regional market growth. Like North America, Europe is also expected to offer significant growth opportunities for the immunoprecipitation market. Increasing investments in research activities by the biotech sector in the region is anticipated to promote healthy market growth over the forecast period.

Global Immunoprecipitation Market: Competitive Players

Some of the prominent players that are operating in the global immunoprecipitation market are Thermo Fisher Scientific Takara Bio Inc., Bio-Rad Laboratories, Merck KGaA, GenScript Biotech Corporation, Abcam plc, Cell Signaling Technology, Inc., Abbkine Scientific Co., Ltd., Rockland Immunochemicals Inc., and BioLegend, among others.

Global Immunoprecipitation Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

Some of the important factors that are augmenting the growth of the global market include rapidly growing life science industry, increase in investment & funding in biopharmaceutical research, and growing R&D activities in genomics & immunotherapy.

Some of the prominent players that are operating in the global immunoprecipitation market are Thermo Fisher Scientific Takara Bio Inc., Bio-Rad Laboratories, Merck KGaA, GenScript Biotech Corporation, Abcam plc, Cell Signaling Technology, Inc., Abbkine Scientific Co., Ltd., Rockland Immunochemicals Inc., and BioLegend, among others.

North America is expected to hold the largest share in the global immunoprecipitation market during the forecast period. The most prominent factors that are fostering the growth of the market in the region include an increase in research & development investments by biological and pharmaceutical companies. The U.S. is expected to hold the dominant market position in North America. This is mainly due to rapid expansion of the life science sector.

 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed